92 related articles for article (PubMed ID: 23031382)
1. Follicular acneiform eruption induced by bevacizumab.
Gavrilova M; Martin JM; Martin-Gorgojo A; Jorda-Cuevas E
Dermatol Online J; 2012 Sep; 18(9):15. PubMed ID: 23031382
[TBL] [Abstract][Full Text] [Related]
2. Acute and severe acne in a patient treated with bevacizumab.
Molina-Ruiz AM; Domine M; Requena L
Int J Dermatol; 2013 Apr; 52(4):486-90. PubMed ID: 23432695
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab (avastin) in ocular processes other than choroidal neovascularization.
Barkmeier AJ; Akduman L
Ocul Immunol Inflamm; 2009; 17(2):109-17. PubMed ID: 19412873
[TBL] [Abstract][Full Text] [Related]
4. Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference?
Graziano F; Cascinu S
J Clin Oncol; 2003 Sep; 21(18):3542-3; author reply 3543. PubMed ID: 12972535
[No Abstract] [Full Text] [Related]
5. Bevacizumab-associated fistula formation in postoperative colorectal cancer patients.
Ganapathi AM; Westmoreland T; Tyler D; Mantyh CR
J Am Coll Surg; 2012 Apr; 214(4):582-8; discussion 588-90. PubMed ID: 22321523
[TBL] [Abstract][Full Text] [Related]
6. Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies.
Grothey A; Ellis LM
Cancer J; 2008; 14(3):170-7. PubMed ID: 18536556
[TBL] [Abstract][Full Text] [Related]
7. [Metastasizing malignant meningioma: a case report].
Latz D; Engenhart R; Ewerbeck V; Wannenmacher M
Strahlenther Onkol; 1991 Sep; 167(9):519-22. PubMed ID: 1925935
[TBL] [Abstract][Full Text] [Related]
8. Overview of anti-VEGF therapy and angiogenesis. Part 1: Angiogenesis inhibition in solid tumor malignancies.
Ellis LM; Rosen L; Gordon MS
Clin Adv Hematol Oncol; 2006 Jan; 4(1):suppl 1-10; quz 11-2. PubMed ID: 16562372
[TBL] [Abstract][Full Text] [Related]
9. Diaphragmatic rupture, a new complication of Bevacizumab.
Lacaze L; Scotté M
Eur J Surg Oncol; 2012 Nov; 38(11):1079-81. PubMed ID: 22818843
[TBL] [Abstract][Full Text] [Related]
10. Targeting angiogenesis in cancer: clinical development of bevacizumab.
Kerr DJ
Nat Clin Pract Oncol; 2004 Nov; 1(1):39-43. PubMed ID: 16264798
[TBL] [Abstract][Full Text] [Related]
11. Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.
Saloustros E; Kalbakis K; Vardakis N; Kalykaki A; Milaki G; Rovithi M; Agelaki S; Saridaki Z; Georgoulias V; Mavroudis D
J BUON; 2011; 16(2):215-8. PubMed ID: 21766488
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic anti-VEGF antibodies.
Lien S; Lowman HB
Handb Exp Pharmacol; 2008; (181):131-50. PubMed ID: 18071944
[TBL] [Abstract][Full Text] [Related]
13. [Splenic hemangiopericytoma].
Gilsanz C; Garcia-Castaño J; Villalba MV; Vaquerizo MJ; Lopez de la Riva M
Presse Med; 1995 Sep; 24(28):1316. PubMed ID: 7501629
[No Abstract] [Full Text] [Related]
14. [Multiple extracranial metastases from a meningeal hemangiopericytoma and severe hypoglycemia: a case report].
Miyamoto S; Matsuda W; Tsunoda T; Sasaki M; Itabashi M
No Shinkei Geka; 2004 Apr; 32(4):367-72. PubMed ID: 15227844
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.
Ferrara N; Hillan KJ; Novotny W
Biochem Biophys Res Commun; 2005 Jul; 333(2):328-35. PubMed ID: 15961063
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of anti-vascular endothelial growth factor monoclonal antibodies in metastatic colorectal cancer.
Chase JL
Pharmacotherapy; 2008 Nov; 28(11 Pt 2):23S-30S. PubMed ID: 18980549
[TBL] [Abstract][Full Text] [Related]
17. Clinical and radiological response with FOLFOXIRI and bevacizumab as third-line therapy after mFOLFOX6 and FOLFIRI failure.
de Melo JV; Vieira de Melo MS; Abad MH
Anticancer Drugs; 2011 Jun; 22 Suppl 2():S19-20. PubMed ID: 21768793
[TBL] [Abstract][Full Text] [Related]
18. Anti-VEGF therapy with bevacizumab for anterior segment eye disease.
Hosseini H; Nowroozzadeh MH; Salouti R; Nejabat M
Cornea; 2012 Mar; 31(3):322-34. PubMed ID: 22157572
[TBL] [Abstract][Full Text] [Related]
19. Suppression of melanoma-associated neoangiogenesis by bevacizumab.
Jaissle GB; Ulmer A; Henke-Fahle S; Fierlbeck G; Bartz-Schmidt KU; Szurman P
Arch Dermatol; 2008 Apr; 144(4):525-7. PubMed ID: 18427047
[TBL] [Abstract][Full Text] [Related]
20. A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy.
Miwa S; Mizokami A; Konaka H; Izumi K; Nohara T; Namiki M
Jpn J Clin Oncol; 2009 Nov; 39(11):745-50. PubMed ID: 19808839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
